Lopinavir
C37H48N4O5
628,80
[1S-[1R*(R*),3R*,4R*]]-N-[4[[(2,6-Dimethylphenoxy)acetyl] amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]-tetrahydro-α-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide;
(αS)-Tetrahidro-N-[(αS)-α-[(2S,3S)-2-hidroxi-4-fenil-3-[2-(2,6-xililoxi)acetamido]butil]fenetil]-α-isopropil-2-oxo-1(2H)-pirimidinacetamida [192725-17-0]
[1S-[1R*(R*),3R*,4R*]]-N-[4[[(2,6-Dimethylphenoxy)acetyl] amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]-tetrahydro-α-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide;
(αS)-Tetrahidro-N-[(αS)-α-[(2S,3S)-2-hidroxi-4-fenil-3-[2-(2,6-xililoxi)acetamido]butil]fenetil]-α-isopropil-2-oxo-1(2H)-pirimidinacetamida [192725-17-0]
DEFINICIÓN
El Lopinavir contiene no menos de 98,0% y no más de 102,0% de lopinavir (C37H48N4O5), calculado con respecto a la sustancia anhidra.
ESTÁNDARES DE REFERENCIA USP A LA VENTA
ER Lopinavir USPER Mezcla de Aptitud del Sistema de Lopinavir USP